No, you should not take naproxen if you have heart failure, regardless of having a pacemaker.
NSAIDs including naproxen are strongly contraindicated in patients with heart failure and should be avoided. The presence of a pacemaker does not change this recommendation—the pacemaker addresses electrical conduction issues but does not protect against the harmful effects of NSAIDs on heart failure.
Why NSAIDs Are Dangerous in Heart Failure
Multiple authoritative guidelines explicitly warn against NSAID use in heart failure patients:
- European Society of Cardiology guidelines specifically state to "avoid non-steroidal anti-inflammatory drugs (NSAIDs)" when managing heart failure patients 1
- ACC/AHA guidelines note that "NSAIDs are generally contraindicated in patients with heart failure" and require documentation of specific indications if used 2
- Canadian Cardiovascular Society recommends that "common drugs that should be used with caution by heart failure patients include NSAIDs" (Class I, Level B evidence) 3
- Most recent 2017 Canadian guidelines provide a strong recommendation against the use of NSAIDs in patients with reduced ejection fraction heart failure (Strong Recommendation; High-Quality Evidence) 4
- 2022 AHA/ACC/HFSA guidelines list NSAIDs as medications that increase sodium retention and worsen heart failure 5
The Mechanisms of Harm
NSAIDs cause multiple problems in heart failure patients:
- Fluid retention and edema - directly worsening congestion 6
- Sodium and water retention - counteracting diuretic therapy 4
- Worsening renal function - interfering with ACE inhibitors/ARBs 7
- Increased blood pressure - adding cardiac strain 6
- Direct cardiovascular toxicity - increasing risk of heart failure hospitalization 8, 9
The Evidence on Naproxen Specifically
While naproxen is often considered the "safest" NSAID from a cardiovascular standpoint compared to other NSAIDs, it still carries significant risk in heart failure patients:
- A large Danish study of 107,092 heart failure patients found naproxen use associated with a 22% increased risk of death (HR 1.22; 95% CI: 1.07-1.39) 8
- A European study showed naproxen increased heart failure hospitalization risk by 16% (OR 1.16; 95% CI: 1.07-1.27) 9
- Even among NSAIDs, naproxen demonstrated dose-dependent increases in heart failure risk 9
- Recent 2023 data showed naproxen initiators after MI or heart failure had a 19% increased risk of adverse outcomes (HR 1.19; 95% CI: 1.08-1.31) 10
The FDA drug label for naproxen explicitly warns: "Naproxen should be used with caution in patients with fluid retention, hypertension, or heart failure" and notes that "fluid retention, edema, and peripheral edema have been observed" 6.
What About the Pacemaker?
The pacemaker is irrelevant to this decision. Pacemakers treat:
- Bradycardia (slow heart rates)
- Heart block (electrical conduction problems)
- Certain arrhythmias
They do not protect against:
- Fluid retention from NSAIDs
- Worsening kidney function
- Increased blood pressure
- Direct myocardial stress
Safer Alternatives for Pain Management
Instead of naproxen, consider:
- Acetaminophen (paracetamol) - first-line for pain in heart failure patients
- Topical NSAIDs - if localized musculoskeletal pain (minimal systemic absorption)
- Opioids - for severe pain under careful monitoring
- Physical therapy and non-pharmacologic approaches
- Tramadol - as an intermediate option
Critical Caveats
If an NSAID is absolutely unavoidable despite these warnings:
- Use the lowest effective dose
- For the shortest possible duration (days, not weeks)
- With close monitoring of weight, symptoms, blood pressure, and renal function
- Preferably under cardiology supervision
- Consider naproxen over other NSAIDs if forced to choose (though still not recommended)
However, the overwhelming evidence and guideline consensus is clear: avoid NSAIDs entirely in heart failure patients. The risk of heart failure decompensation, hospitalization, and death outweighs any analgesic benefit in this population.